• Drug discovery and development
• Academia & technology/knowledge transfer
  • Universities/research institutes and spin-out companies
  • Centres of excellence: disease focus
  • Centres of excellence: drug discovery & development process
• Facilities and Services
• Grants and Finance
• Other Contacts and Services

Universities/Research Institutes and Spin-Out Companies

Entrepreneurial culture is encouraged in all London universities and no less than 50 biopharmaceutical companies have been spun out (excluding medical device and imaging companies). As well, academia attracts substantial research funding from industry and a number of specialist research facilities are partnerships between universities and pharmaceutical/biotech companies. Imperial College London, for instance, has existing partnerships and collaborations with GlaxoSmithKline, Johnson & Johnson, Affymetrix and Invitrogen.

Some of the most active commercialisation/technology transfer offices are featured here.

  University business/technology transfer offices

For more information and contact details, click on the name of the organisation.

 

Name	Description
Brunel University, West London	Brunel University has an excellent record in developing successful and beneficial relationships with business and industry, locally, nationally and internationally.
Cancer Research Technology	CRT sources, develops and commercialises new cancer therapeutics, vaccines, diagnostics and enabling technologies.
Imperial Innovations	Imperial Innovations integrates the activities of technology transfer, company incubation and investment.
King’s College London Business Ltd	King’s College London Business Ltd is responsible for business development and commercialisation of the research and technologies emanating from King’s College London.
MRC Technology	MRCT is the exclusive commercialisation catalyst for the UK Medical Research Council (MRC), working to translate cutting edge scientific discoveries into commercial products.
1 2 3